MoneyWorks4Me

Sudarshan Pharma Industries informs about annual secretarial compliance report

30 May 2026 Evaluate
Pursuant to Regulation 24A of SEBI Listing Regulations read with SEBI Circular no. CIR/CFD/CMD7 27l2ol9 dated 8th February, 2019, Sudarshan Pharma Industries has enclosed the Annual Secretarial Compliance Report issued by Vishal Manseta, Company Secretary in Practice, for the financial year ended 31st March 2026.

The above information is a part of company’s filings submitted to BSE. 

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..